Objective: To report the experiences of 66 surgical specialists from 15 different hospitals who performed 43 CPT-based procedures more than 16,000 times. Summary Background Data: Surgeons are under increasing pressure to demonstrate patient safety data as quantitated by objective and subjective outcomes that meet or exceed the standards of benchmark institutions or databases. Methods: Data from 66 surgical specialists on 43 CPT-based procedures were accessioned over a 4-year period. The hospitals vary from a small 30-bed hospital to large teaching hospitals. All reported deaths and complications were verified from hospital and office records and compared with benchmarks. Results: Over a 4-year inclusive period (1999 -2002), 16,028 elective operations were accessioned. There was a total 1.4% complication rate and 0.05% death rate. A system has been developed for tracking outcomes. A wide range of improvements have been identified. These include the following: 1) improved classification of indications for systemic prophylactic antibiotic use and reduction in the variety of drugs used, 2) shortened length of stay for standard procedures in different surgical specialties, 3) adherence to strict indicators for selected operative procedures, 4) less use of costly diagnostic procedures, 5) decreased use of expensive home health services, 6) decreased use of very expensive drugs, 7) identification of the unnecessary expense of disposable laparoscopic devices, 8) development of a method to compare a one-surgeon hospital with his peers, and 9) development of unique protocols for interaction of anesthesia and surgery. The system also provides a very good basis for confirmation of patient safety and improvement therein. Conclusions: Since 1998, Quality Surgical Solutions, PLLC, has developed simple physician-authored protocols for delivering highquality and cost-effective surgery that measure up to benchmark institutions. We have discovered wide areas for improvements in surgery by adherence to simple protocols, minimizing death and complications and clarifying cost issues.
Q uality Surgical Solutions (QSS), PLLC, was formed in 1997 by a group of surgical specialists who sought to restore the role of surgeons in defining improved quality care, health system leadership, and better practices to control costs. Pressure to show such evidence of improved quality care is increasing and was the impetus for 2 books: To Err Is Human in 2000 and the subsequent publication of Crossing the Quality Chasm. 1, 2 In To Err Is Human, the authors claim that 44,000 to 98,000 Americans die of iatrogenic illness, a result that they extrapolated from 33.6 million admissions to U.S. hospitals in 1997. [3] [4] [5] To what extent this is actually true remains to be seen. 6 Evidence of improved quality care has been reported in risk-adjusted prospective data from the Department of Veterans Affairs (VA) and the National Surgical Quality Improvement Project (NSQIP). [7] [8] [9] [10] These studies indicated that 30-day, all-cause complication and death rates were 10% and 2.8%, respectively. Neither study attributed adverse events and error rates to the processes of surgical care that are influenced by the surgical practitioner. These outcome studies have become respected standards for contemporary surgical quality studies.
In 1992, McGuire et al 11 reported on 44,603 consecutive major operations performed at a large medical center from 1977 to 1990. They found that 5.4% of patients sustained at least 6.3% of complications, while 49% of these complications were attributable to recognized error. A total of 749 patients (1.8% of the whole) died during the same hospitalization and 7.5% of these deaths were also attributed to "error."
Many hospitals have elaborate (and we have learned faulty) systems for accounting, but few have processes for reporting genuine quality. Fewer still are able to correlate any data with actual cost accounting of an operation. Major efforts to embrace expensive programs mandated by hospital certification agencies and designed by administration, nursing, or ubiquitous consultants have largely been a disappointment. Because of fear of discovery and the adversarial use in medicolegal matters inherent in these programs, the reporting of complications and deaths continues to be impeded.
To be meaningful, error and mortality rates also must be adjusted for risk, as manifested by ASA scoring, which is a major risk variable used by the NSQIP system. A patient with an ASA classification of 1 tolerates any complication better than a patient with an ASA score of 4. Palliative surgery (ie, complete bowel obstruction in a patient with metastases and associated cardiac disease) must be considered differently from a patient who undergoes elective surgery as a cure for colon cancer. Furthermore, intensive surgical care has led cardiac surgeons to stress the need for more sophisticated and accurate stratification of risk. [12] [13] [14] Anesthesiology made great strides more than 2 decades ago in safely reducing their mortality rate from 1 in 10,000 to 1 in 200,000 or more. [15] [16] [17] [18] [19] The gains in anesthesia have been secured through improved monitoring, the development and widespread adoption of practice guidelines, as well as other systematic approaches to reducing errors. 20 Practicing surgeons are being urged to redefine their professional competence and to demonstrate patient safety data, which measures objective and subjective outcomes that meet or exceed the standards of benchmark institutions or publications. Surgical report cards, and all that they imply, are here to stay. Notably, our practice patterns vary widely and are not easily explained or justified; this is especially true for many surgical specialties.
Five years ago, 46 surgical specialists from 11 different communities utilizing protocols that were developed by consensus groups within the respective disciplines began to collect their own data on 10 CPT-based procedures, principally in the elective setting. This group has grown to now include 66 surgical specialists and 43 CPT-based procedures. Some of the results of this experience are reported herein, formally for the first time.
Center for Medicare/Medicaid Services (CMS) Emphasis
Many surgeons are pleased that many elements of health plans and government payors have begun to focus on the quality of medical care. The current administration is initiating a detailed and focused study of surgical morbidity and mortality rates wrapped in a climate of enhancing patient safety and minimizing medical error (Surgical Care Improvement Project). The pilot projects have begun and are seeking to study performance measures related to common procedures on Medicare beneficiaries, with substantial emphasis on major surgical procedures, such as total hip and knee replacement, colon resection, major vascular procedures, hysterectomy, and coronary artery bypass. QSS is participating in this study with Health Care Excel, the Medicare quality improvement organization (QIO) for Kentucky, along with the QIOs in Ohio and Oklahoma. This is a commendable effort to define quality outcomes in terms of low mortality and low morbidity rates and to develop better practices that can be measured and assimilated broadly across the country. Similar studies in the past have focused on expensive abstracting of entire charts by nurses at remote sites; it will be especially interesting to examine the impact of reporting by QSS physicians performed inexpensively and proximate to the time of their patient care service, permitting easy inclusion of postdischarge patient status. Opportunities to verify the accuracy of these data and comparisons abound. It once again may put surgeons in a position to report, verify, and improve upon their own performance.
Prior studies by the CMS have focused on surgical antibiotic prophylaxis and disclosed a relatively high proportion (88%) of patients receiving appropriate drugs for prophylaxis. CMS similarly found that results with respect to timeliness of initial preoperative administration of drugs were satisfactory (88%), but they were often continued for unacceptably long periods of time postoperatively (48%) (unpublished data). These types of precise indicators can be further surrogates for quality of care and have also been addressed by QSS in its own internal studies ( Fig. 1 ). Other performance measures rapidly come to mind, including maintaining glucose (Ͻ 200 mg/dl) in diabetes, specific deep vein thrombosis prophylaxis in documented high-risk procedures, and use of beta blockers after cardiovascular operations.
The quality and safety initiatives are not new; surgeons have been excluded and/or opted out of this entire contemporary quality process. For example, a recent Institute for Healthcare Improvement forum was attended by only 6 sur- 
MATERIALS AND METHODS

Experience
The surgeon-owners of QSS, PLLC, invested a total of $3000 in 2 separate payments over 1 years' time to found the company. This funding was supplemented by a substantial grant from Anthem Blue Cross-Blue Shield and by contracts with a variety of teaching and nonteaching hospitals to support the program as a small part of each individual hospital's overall quality improvement effort.
Quality was defined as the best outcome as a function of comparable cost. The development of a simplified protocol and report form that focused on factors of care that impacted quality ( Table 1 ) was essential and focused upon certain demographic data, the indication for operation, preoperative factors and evaluation, the operation itself, the postoperative recovery period, and the return to work. To allow for individual patient differences, each practice protocol allowed a 10% variance from the recommended guideline. Adverse events were reported, and the data validation process has been subject to a random 2% verification experience, working primarily from the surgeon's office chart. The principles of the group were carefully constructed so that payments to the business entity were in full and total compliance with the evolution of Stark I and II with respect to physician inurement by hospitals. Both volume and quality parameters participated in the indirect reward to physicians by QSS for those who were reporting their clinical experience directly to QSS.
The initial group of 46 surgical specialists in the specialties indicated in Table 2 now includes 66 surgeons with a similar distribution. Our initial configuration focused upon 10 of the most common and straightforward simple elective operations common to the specialties of general, otolaryngologic, and urologic surgery. This has now been expanded to 43 CPT-based groups of operations that encompass most of the operations performed by QSS surgeons in these surgical special-ties, plus orthopaedic and gynecologic surgery. Tables 3 and 4 itemize the CPT-based procedures studied.
The diversity of surgical specialties involved was undertaken to stress the broad applicability of these concepts. Surgeons invited to join QSS were uniformly certified and recertified, if appropriate, by the American Board of Surgery and were Fellows of American College of Surgeons or the American Academy of Orthopedic Surgeons. All held either full-time or volunteer faculty appointments at the University of Louisville School of Medicine. At no time did the full-time faculty constitute more than 35% of the number of surgeons participating in QSS, and they never contributed more than one fourth of all patient volumes reported. The representative nature of our practice environment, which represents a real world surgical practice in mid-America, was thought to be important. The organization developed a small, lean office staff capable of collecting information and operating with several primary goals: 1. Regular feedback to sponsoring hospitals and surgeons about their performance.
2. Heavily attended monthly board meetings included hospital sponsors, who ranged from chief executive officers of large systems to chief financial officers of smaller hospitals, and later wisely included the director or supervisor of the operating suites. Community leaders, such as attorneys, accountants, nurses, consultants, other related business entities, and a former state Director of Medicaid Services, all participated in these meetings regularly. Evolving data were reported and discussed at each meeting in detail, and continued refinement of the data collection or practices occurred.
3. Paid annual meetings for the participants in the program were accomplished coincident with major Grand Rounds' programs at the University, which also focused on megatrends in quality measurement and economic considerations. These meetings led to a reformation of University teaching conferences to focus upon core competencies, patient safety, conversion of Mortality and Morbidity reviews to a Quality Improvement format, and regular reports on hospital and physician changes for certain common surgical illnesses. Near-miss reporting has become a popular method for emphasizing patient safety.
It rapidly became obvious that our hospital data permitted study of the impact of a multitude of choices by surgeons on overall hospital charges and payments. While the practice guideline was thought to be very high and the initial procedures were all elective, untoward events were uncommon. However, wide ranges of economic performance were identified, and QSS worked with the hospital finance departments to evaluate the usefulness of participating under our protocols compared with those surgeons who did not. Interestingly, approximately half of the surgeons invited to join QSS chose not to participate. These similarly well-qualified surgeons and their clinical work became valuable controls for studying financial data within the otherwise homogeneous hospital staff.
RESULTS
Measurable Outcome
The total QSS accrual starting in 1999 reached 16,028 in 2002. The complication rate varied from 1.2% to 1.4%. The death rate was always under 1% and our average complication rate was 1.3%. Results of formal verification studies of our data indicate that all of the deaths were reported, but only approximately one half of the complications were reported, suggesting a more accurate complication rate of approximately 3%.
Forty-three different CPT code groups were performed, each with different protocols. A total of 66 surgical specialists were involved in performing these operations, and this occurred in hospitals in different cities ( Table 2) . A wide range of improvements have been identified and implemented with varying success. Classification and clarification of indications for systemic prophylactic antibiotic use in laparoscopic cholecystectomy decreased the use of perioperative antibiotics from 70% in 1999 down to 35% and reduced the drugs or drug combinations used from 13 to 5 ( Fig. 1 ). We discovered a simple item in a standard preoperative order set that promoted excess antibiotic use in one institution and altered the order and lessened the discrepancy.
A shortened length of stay for standard procedures in different specialties has occurred, and continues to occur, nationwide. We have moved this process more rapidly through patient education, staff expectations, and peer influence. As opposed to hospital administration pejoratively prompting shorter stays, this has been accomplished by demonstrating true peer performance. An example of reduced length of stay is a colon resection that was reduced from 5.5 average days to 2.5 days. One highly respected surgical group was well behind the QSS curve for length of stay after laparoscopic cholecystectomy; comparison of their data to the broader peer group favorably altered their length of stay within 6 weeks. Use of protocols combining anesthesia and surgery safely reduced preoperative cardiology consults. The Quality Care, Safety, and Cost Control use of Duplex scanning-only in carotid artery disease increased from 10% to 40%, producing a substantial savings for some patients while eliminating a 1% stroke rate. We reduced the use of expensive drugs such as Zofran and Lovenox, when they were unnecessarily used.
We have achieved only moderate success in encouraging patients who have had hernia repair to return to work earlier. Return to work improved only 7% per year, no doubt influenced by social expectations, business practices, and union demands, more than any refinements in our care or physician and patient education schemes.
QSS created a web site (http://qualitysurgical.com) for patient education, especially with respect to what is expected from operation and recovery. There was wide distribution of a book entitled When to Refer to a Surgeon 21 for nurse practitioners and primary care doctors, reinforcing the concepts of when a surgeon should see a patient in the first place. Interestingly, many informed patients found the book and website useful. We also developed a mechanism in which single surgeons working in small hospitals can compare their data with other surgical specialists so as to reassure their boards and colleagues of their quality of care. 22 We already have identified the importance of maintaining up-to-date preference cards and the huge cost savings associated with this. 23 More importantly, we uncovered the huge cost for disposable instruments used in laparoscopic surgery. We compared the costs of laparoscopic cholecystectomy in one hospital among 10 different surgeons and found that the total cost of disposable instruments varied from $92 up to $637; the surgeons promptly moved to less expensive choices whether within or outside QSS. We created surgeryanesthesiology protocols at one teaching hospital, which yielded the following results: 1) safe reduction in preoperative cardiology consults, 2) decrease in home health use, 3) an increased proportion of patients arriving at the holding area with all evaluations completed, 4) reduced time to induction to a mean of 34 minutes, 5) reduced transfer times to PACU by 16 minutes, and 6) decreased use of postoperative antiemetics. In the most frequently used nursing unit, medication errors were reduced as were other reported adverse events related to the wider use of standard order sets for the entire admission and acceptance of surgeon-led clinical pathways.
All of the above have had a measurable impact on quality efficiency and cost. We have completed a profitable and ethical trial of antibiotic choices in the management of lower extremity soft-tissue infections requiring operation and have several others under study. The real world nature of this cohesive surgical specialty group appears to appeal to industry clinical research program directors.
Impact of Experience
This experience indicates that surgeons can and will take the lead in efforts to enhance quality patient care and safety; this is especially important because this project has been and is led by privately practicing surgical specialists in mid-America. Surgeons, administrators, operating room directors, nurses, and financial and information mavens can work harmoniously toward such altruistic goals and add meaningful observations and changes related to the costs associated with surgical care. Despite reservations about the ongoing crisis in professional liability matters, practicing surgeons embrace enhanced transparency of their practices, judgments, and technical accomplishments. To prevent this report from becoming an uncodeable logarithm table, we will specifically focus upon some conclusions that are, in our opinion, more substantive than others.
Our data reported by surgeons and accessioned are reviewed for common sense by a surgeon. Verification studies are ongoing and generally reassuring. Patient satisfaction studies express great admiration and affection for their surgeon and general approval of all aspects of our work, except the clarity of our bills and the convenience of parking. We also assumed there would be outliers. We never sought perfection, just "better" practices on the way to "best" practices. Each year the proportion of patients accepted as outliers was lessened, a progressive raising of the bar in most categories for every procedure.
Acalculous cholecystitis, also known as "HIDA scan positive cholecystopathy," has posed special problems and provoked hours of debate. With the presumed increasing safety of laparoscopic cholecystectomy (Fig. 2 ), many more patients with "lazy gallbladders" are referred for operation and in some of our practices approach 35% of the total. We also note that a growing number of reports suggest that abatement of symptoms is similar in these patients to those with gallstones.
We have significant data on other "topical" surgical issues. Kentucky surgeons a decade ago had been criticized in our lay press for being slow to embrace breast conservation; our data show that half of our patients are so treated, and the proportion is slowly rising (Fig. 2) . We have separately discussed the cost savings of substituting Duplex-only evaluation for routine angiography in evaluation of patients undergoing carotid endarterectomy as a preoperative measure for controls ( Fig. 2) . Our group is steadily moving toward some published norms for embracing this practice. Interestingly, sentinel lymph node biopsy for breast cancer caught on much faster, probably because of a major role in that process by our faculty and residents. 24, 25 We have referenced our experience with the discarding of some very expensive medications for which more economical choices with comparable efficacy can be entertained. Curiously, the drug industry does not capture the enormous number of drugs ordered by surgeons, in part because much of it has been ordered historically in the hospital. The opportunity for judicious surgical practices to influence pharmaceutical costs is underappreciated. For example, in Kentucky, much fiberoptic gastrointestinal endoscopy is performed by general and colorectal surgeons; accordingly, long-term drug choices are frequently made by surgeons for gastroduodenal ulceration, reflux esophagitis, and inflammatory bowel disease. The opportunity for good surgical citizenship shows up in our work over and over.
Surgeons' preference cards, 23 as noted, now are no longer choices for catgut or silk, but are potential budget busters. Again, once informed, and especially if reinforced by operating room assistants with choice of very well-maintained reusable devices, surgeons readily assume a responsible leadership role.
We have developed a broad, sustained, and moderately successful focus upon the extraordinary expense of home health services as well as rehabilitation choices after joint replacement. We have found that nurse practitioners working with our surgeons and providing video camera images of many wounds can obviate much of such services.
Interestingly, a separate report on colorectal resection by our QSS colleagues has disclosed interesting practice patterns; essentially 80% of colon resections are performed by general surgeons and 80% of rectal resections are performed by colorectal surgeons (unpublished data). The unique surgery-anesthesiology protocol and entire admission order sets implemented by our colorectal surgeons are mentioned elsewhere.
DISCUSSION
The lead article for General Surgery News of September 2003 is entitled "Track Your Outcomes." 26 Whatever your opinion is about quality of measurements in surgery, tracking one's basic steps leads the way toward a personal quality evaluation. These are strong words and are frightening to most surgeons. The same old adage applies (ie, "if we don't do it for ourselves, the government or some other third party will"). Some hospitals require surgeons to maintain electronic records of their cases, which are then analyzed by nonsurgeons for quality assessment. The Joint Commission appears to be using performance measurements to compare standards of hospitals and individuals more frequently. It is also possible that payors will only deal with surgeons who actually participate in outcome analysis of their practice, including active and specific assessment of patient risk.
The Institute of Medicine claims that there are between 44,000 and 98,000 Americans who die of iatrogenic illnesses annually. Brennan et al 4 reported that adverse events occurred in 3.7% of 30,000 hospitalized patients, and 27.6% of these adverse events were said to be caused by negligence. Although 70% of the adverse events gave rise to disability lasting less than 6 months, 2.6% were said to have caused permanent disability and 13.6% death. There was a significant difference in the rate of adverse events among categories of clinical specialists, but no difference in the percentage found to be caused by negligence.
Leape 5 reported that drug complications were the most common form of adverse events, representing 19% of all adverse events, followed by wound infection (14%) and technical complications (13%). Nearly half of the adverse events were associated with operations. None of these are, in fact, surprising. Fortunately, adverse events during surgery itself were less likely to be caused by negligence, estimated at only 17%. To some degree, it is reassuring that diagnostic mishaps presented 75% of all negligent events. Most of the diagnostic mishaps were predominantly errors of omission. Seventy percent of the negligent events occurred in the emergency room. Errors in management were identified in 58% of the adverse events and, among those, nearly half were found to be attributable to negligence.
Surgeons are under scrutiny because it is easier to identify mishaps associated with technical procedures. Importantly, we have found that the practice patterns that lead to low morbidity and mortality rates and quality standards that were established by QSS surgeons were fairly frequently and promptly adopted by non-QSS surgeons. One hospital found that non-QSS surgeons ultimately approximated the outcome of the QSS surgeons, tracking behavior within 9 to 12 months. We think that emulation of better practices is good for everyone, most of all our patients.
Perhaps the most impressive quality data produced so far have been the VA NSQIP reports in multiple formats. 7-10 A total of 417 different major surgical procedures performed from 1991 through 1997 were studied prospectively. Since 1994, the 30-day operative morbidity and mortality rates have Quality Care, Safety, and Cost Control progressively fallen. Compiled from valid information and based on patient presurgical risk factors, some process of care data during surgery and 30-day morbidity and mortality rates are available for all major procedures at the 123 VA Medical Centers. With this, the VA has established the first prospective outcome-based program for comparative assessment and enhancement of quality surgical outcomes among multiple institutions and several surgical subspecialties; interestingly, improvements in reporting and care appeared to follow.
The key features of the success of the NSQIP are the support of the surgeons who practice in the VA centers. The data are collected by dedicated nurses who are independent and do not have immediate supervisors in the hospitals where they work. The results of this progress have already included a decrease in mortality and morbidity rates. Furthermore, the VA was able to demonstrate that some surgical subspecialties (eg, urology and orthopaedics) demonstrated a positive impact on the Veterans' overall health status. No surgical programs have been closed or merged solely on the basis of NSQIP results as of this time. However, surgical programs with better-than-expected outcomes did appear to have better process and implementation of surgical care, emphasizing that the problems in surgical errors may be more often due to system errors than individual problems. The American College of Surgeons has now partnered with the VA to expand the NSQIP to include more nonfederal surgeons. Today, NSQIP is available at 17 hospitals in the private sector nationally.
One of the few other reports in the literature addresses the 30-day postoperative death rates at an academic medical center. This study demonstrated a patient death rate of 1.9%, 30 days postoperatively. 27 Seventy-two percent of these deaths were attributable to patient's primary disease; however, 19 .3% of all deaths could not be attributed to the patient's primary disease and were thus suspicious for an adverse event as the cause of death. Of the 23 deaths suspicious for an adverse event, 15 were classified as potentially preventable, affecting only 0.24% of the studied population.
Our work demonstrates that a large number of patients can be operated on for various conditions with extremely low mortality and morbidity rates. Not only was there demonstrable quality care, but we also demonstrated several additional cost-effective approaches for providing good quality care to our patients.
Limitations
The results of our study, however, are limited by various factors. Even though this was a prospective study, there were certain flaws intrinsic to the methods in which patients were selected. A few QSS surgeons often chose to participate minimally, and those who did participate did not necessarily enter all patients. Several verification efforts disclosed that no deaths went unreported. Second was the surgeons' possible motivation to enter patients who were associated with a certain health plan or with a certain hospital, either of which was funding the reporting process. Crossreferencing financial data and verification studies disclosed no pattern of systematic exclusion.
We did not prospectively evaluate adverse outcomes per se to determine whether they were preventable or not. We were able to cross-reference initially all hospital data with the reports that the surgeon provided to us. The mortality rates were accurate; however, our office chart verification found that complications were underreported by the surgeon by approximately half. This was in part attributed to the QSS patient being identified throughout the entire episode of care.
Financially, our specific data showed that the hospitals and insurance companies could not separate information about patients that were solely based on surgical practice and/or operative procedure. For example, assume that a patient visited an internist and has basic laboratory data and workup and then visited a surgeon and underwent an operation; health plan data are often based on an episode of care and could not differentiate what part of that cost was applied toward the tests and toward the operation. We had similar problems, but less severely so, with correlating information from hospitals with the specific surgical procedure. Notwithstanding, our efforts uncovered a treasure trove of financial data that indicated we could improve both process and outcome, often with significantly measurable savings.
We also learned that medical directors who work for health plans have little control over what the plans' internal policies are and how they are applied.
We recognize that there also is a fundamental conflict between saving money for the insurance companies and saving money for the hospitals. If we were able to prove that we could save money for the health plan, this often meant that the hospital lost money, sooner or later. An example of that, a patient who has carotid stenosis and only has a Duplex scan and subsequently has a carotid endarterectomy based on the Duplex scan, saves the insurance company at least $2000 of charges because the patient did not have an angiogram; however, the hospital loses the revenue from that angiogram. The charges for the hospital and physician component of a carotid arteriogram approaches $2000; the marginal savings for an arteriogram is only $400, since the space and equipment are available and the technical personnel is on duty anyway. Therefore, this creates a very real "Catch 22" situation for the general scheme of saving health care dollars within our current system and is magnified repeatedly within our "system" of surgical care. Furthermore, certain hospital "savings" will soon be recognized as such and downward adjustments made in the next round of negotiations between the hospital and the health plan.
Study Implications
Nearly all experts in health care, from physicians and healthcare administrators to health services researchers, government, and the privately insured agree that our current healthcare system is not working well and will have to be revised, if not revolutionized. Certainly, our patients' safety must play an extremely important role in this endeavor. 28 Studies of surgical adverse events in Colorado and Utah documented a very high incidence of adverse events parallel to the Institute of Medicine report. 3 Brought to the forefront were many problems associated with the current health system, including poor outcomes from surgical operations. Certainly, surgical report cards are becoming the norm. The upcoming presidential campaign is already focused on health care and, not surprisingly, Gingrich et al 29 has just released a book entitled Saving Lives and Saving Money.
We show herein that 66 surgeons can be organized and report their complication rates and death rates and develop new ways to promote safety and quality surgical care while reducing some expenditures. Our goal is to further improve the process so that all patients are enrolled, and all complications and deaths are reported accurately. How new HIPAA rules will interfere with this process in collecting patient data is unknown at the present time. Hopefully, organizations that collect this type of data can work as business associates similar to the arrangement established by the Commission on Cancer and various "approved" hospitals. One of the largest impediments in collecting data and attempting to improve patient safety continues to be discoverability for future liability suits and how society will protect hospitals and physicians as they share their data for altruistic ends. In the state of Kentucky, all peer review is discoverable, and this has been confirmed 3 times at the State Supreme Court level.
The value of this kind of data depends on what we accomplish and what favorable outcomes occur as a result. For example, it is said to cost the VA only $38 per patient per major procedure for NSQIP data collected. Our process has been similarly and relatively inexpensively accomplished. Who should pay for these studies? With the increasing costs of health care and declining reimbursement for hospitals and physicians, where should the money come from? Once again, it appears reasonable that modest allowances for such health services research should be included in the vast and ponderous system.
CONCLUSION
Surgeons working together under one umbrella with simple self-authored protocols can generate data on their surgical practice, including morbidity and mortality rates. With these data, they can generate cost savings and identify opportunities to improve patient safety and outcome. Discussions DR. R. SCOTT JONES (CHARLOTTESVILLE, VIRGINIA): I want to compliment Dr. Shively, his colleagues, partners, and associates for their forward thinking and the programs that they have developed ahead of the curve.
For a background comment, I have had an opportunity during the last year or 2 to participate in some quality improvement organizations, including the National Quality Forum and CMS. Everyone probably knows that CMS has a quality improvement program for their Medicare beneficiaries. Dr. Shively referred to Medicare's Quality Improvement Organization (QIO) toward the end of his talk.
There are 54 QIOs sponsored by CMS. There is one in every state, one in every territory, and one in the District of Columbia. And they have contracts with CMS to carry out quality improvement programs.
The reason I mention this is that those programs have been in place for a long time. They started as PSROs, PROs, and then recently in the mid '90s they became quality improvement organizations. And I think that is what they are trying to do. Now, they have paid attention to a lot of things in the past: diabetes, hypertension, and other chronic diseases. But more recently in the last several months, they are turning their attention to quality of care in surgery. And that is where this comes down to Dr. Shively's work.
I think that surgeons throughout this organization, in fact throughout the United States, need to pay attention to what they have done and be prepared to follow through the similar kinds of organizations and efforts, because I believe that CMS is going to foster this kind of activity from coast to coast. And I think it is going to be essential, for these processes to be successful and do the kind of things that need to be done, to have participation by practicing surgeons. In other words, that is the only way that this can really be done successfully. And Dr. Shively and his associates have showed us how to do this. I wanted to ask 2 questions.
Please give us a little bit more detail about his corporate organization in the discussion. I realize that the doctors are collecting the data with the form, but could you tell us a little more about, for lack of a better word, the corporate structure or the organizational structure of this program?
And as a corollary to that question, if you could elaborate a little bit on your system of data management, data analysis, and reporting. Who gets the data? Who collects the data? Who owns the data? And how and when do the various stakeholders get reports?
Thank you very much for the privilege of discussing this work. I think it is very important. And I think we will probably be hearing more about these kinds of programs in the future.
DR. FREDERICK L. GROVER (DENVER, COLORADO): I too want to congratulate Dr. Shively on exemplary professional leadership as demonstrated by this work. Dr. Richardson, in his presidential address earlier this morning spoke about surgeons taking charge of their future and demonstrating leadership rather than reacting and being victims of a process.
I have been involved for a long time with the Society of Thoracic Surgeons Database and Quality Improvement Project. It is interesting that this project began in the late 1980s to enable the practicing cardiothoracic surgeons in the community to collect their data and compare them to national data from their peers for quality improvement. It has now grown to over 451 participating groups with over 2 million patients entered. This database also has shown a decrease in risk-adjusted operative mortality, length of stay, and costs, demonstrating that you can cost contain without sacrificing quality.
Bruce Ferguson from our group, with support from AHRQ, demonstrated that by feeding back information on best practices and accepted processes of care, you can improve surgical practice.
One aspect of this activity that has really been particularly rewarding has been our involvement in public policy, working with states, the federal government, HMOs, buyers of health care, including Leapfrog, and most recently with the National Quality Forum. So one of the exciting things for us is that in addition to the quality improvement that we hope to directly help our surgeons with to benefit their patients, we hope that by proactively impacting healthier policy to further that effort. So I would be interested whether you plan to broaden your activities and scope of work into this area as well.
DR. R. PHILLIP BURNS (CHATTANOOGA, TENNESSEE): Dr. Richardson, I hope you will extend my compliments to the Program Committee for selecting a number of papers for the program this year that deal with medical or surgical process analysis or development, surgical education, or governmental directives that we surgeons face as challenges.
As indicated in Dr. Richardson's presidential address regarding the opinions about the good qualities of a surgical chairman, attitudes and focus of surgeons are presently different than I remember in past years. If one listens to surgical lounge discussions, they frequently are dominated not by discussions of new or improved surgical techniques or surgical treatment, but by topics such as HIPAA, difficulties or inadequacies in surgical training ushered in by external forces such as the 80-hour workweek, and speculation on the effects that clinical pathways and standardized assessments of quality care may have on our surgical practices and therefore our lives. Frustration, paranoia, and uncertainty abound to the point that many are abandoning surgical practice early or, worse still, discouraging our youth as regards a career in medicine or surgery. This paper by Drs. Shively, Polk, and others should make us feel better about the leadership role surgeons have taken in the area of quality assessment that has effectively led to the use of clinical pathways by the Kentucky group in a variety of practice settings for a veritable cafeteria of issues and results are raised that deserve attention, discussion, and/or questions, and I recommend the manuscript to the membership for review when published.
Just a few of several questions that I have include: Can you tell us more about how you convinced hospital attorneys to approve these contracts? Ours have consistently denied us the opportunity to participate in this program and other similar programs based on real or perceived Stark violations.
Your paper indicates peer-reviewed material is discoverable in Kentucky. If so, are you doing the plaintiff attorney's work for them in preparation of their cases?
Will maintaining funding for this program be a problem long term? I can see short-term benefit to the hospital and insurance companies to lower costs and increase profits, but will their support continue over time? Our insurance payors in Tennessee are pretty much adherent to the lowest fee schedule determining membership in surgical provider panels. Will they ever be willing to pay a premium for proven quality improvement?
And last, a technical question on a more specific note in regards to the laparoscopic trocar issue. Are the altruistic benefits of improved hospital profits alone enough to influence your surgeons to change from expensive disposable instruments such as trocars to far more cumbersome reusable models, or did an individual or committee dictate this change?
Again, I enjoyed this paper. And I am especially appreciative of the last sentence of your abstract published in the Southern program that states, and I quote, "The surgeon remains the most informed and effective advocate for his or her patient." I believe this to be true and hope it remains so.
DR. HIRAM C. POLK, JR. (LOUISVILLE, KENTUCKY): Quality Surgical Solutions began as a quality improvement organization, and it added some skills in financial analysis. It has been a tumultuous and busy 6 years. QSS has consumed an enormous amount of time and effort on many of our parts, and we appreciate the comments by Dr. Jones, Dr. Grover, and Dr. Burns. Let me speak to those in sequence.
First of all, Dr. Jones mentioned a wonderful perspective about the real role of these quality improvement organizations and their liaison with CMS. We have been asked, along with the state of Oklahoma, to try to do the pilot project to identify quality performance measures and I will close with some comments about that. One can look on QSS as a phase 1 experiment. What we may now enter is a phase 2.
Our corporate structure is a PLLC. It has rotating leadership among our clinical faculty. Neal Garrison has been the heart of our data collection instrument, but every report is reviewed by a surgeon to be sure that it makes sense. We have a small, lean staff. We try to do quarterly reports, but in fact we get them out only 2 or 3 times a year. We make available to our surgeons on request their performance compared to others in areas in which we have enough volume to tell them something meaningful. So the structure is a small simple one, a small 2-person office, but a lot of work and a lot of initiative comes from others.
Dr. Grover has brought up the important role of the STS in beginning this kind of effort a decade before anyone else did. I would like to say to him that we found out quickly surgeons emulate better practices quickly and painlessly. As soon as they learn from a colleague that something might be better or simpler, they adopt those methods quickly.
That also applies to the trocars, Dr. Burns, because in truth, we simply posted in the surgeons' lounge of 1 hospital these performance levels in an anonymous fashion. The surgeons with the high cost figures of a very large amount of disposable equipment began to use more and more reusables. So I think surgeons really do want to do the right thing for the right reason.
The issue about professional liability is an important one. Two separate insurance companies have had serious discussions with us about providing credits against the premium for surgeons who participate in this program, but none of them has done so. I think Dr. Burns' statement was a broad overview with understanding of what is really important. He focused on the Stark rules.
First of all, the same Washington law firm that wrote much of those regulations wrote our contract. Then it was quite clear that we must keep up with Stark I and II, which changes from month to month and time to time. We created an interface by which a sponsoring entity provided support to Quality Surgical Solutions and then QSS redistributed a portion of that money to those surgeons who participated in the program in both a quantitative and qualitative way. We believe that there is an arm's length relationship there that makes that acceptable. It is very interesting now that there are leading figures in the Administration in Washington who really would like to see a class action attack on Stark II as an anti-competitive process that interferes with best patient care. I don't think we will tackle that, but I think that is an interesting turn from something that was the truth, the light, and the way 5 years ago to something now that is seen to have its own problems.
Let me close as Dr. Shively did with directing your attention to the prospective study that we will begin in January 2004 for CMS, a prospective study of quality performance measures in 6 common operations that we are going to study across the state. The sort of things we are going to look at are: Are there valid risk measures? What about an albumin of under 2 and maintaining glucose under 200? The proper use of prophylactic antibiotics was discussed at length earlier this morning. A rational plan for DVT prophylaxis for any procedures. Genuine patient education processes. And finally, a careful and perhaps ever more careful interpretation, with your help and other groups like the Southern, of how to interpret and best use this experience.
There is a goal for the first time in my lifetime to consider paying surgeons and hospitals for quality care. They want to know what those measures are. We hope QSS can kind of be a first step to begin to help doctors work together to define those measures that might justify not only for our government but for our patients that increased payment can be directly linked to improved care and better outcomes.
